| Patent application number | Description | Published |
|---|
| 20080230109 | Solar Cell Module and Method For Its Production - A solar cell module and a method for the production thereof, are used in particular in the field of concentrating solar technology. The solar cell module has a large number of two-dimensionally disposed solar cells. These solar cells are applied on a substrate which is coated with a metal layer on the surface orientated towards the solar cells. The metal layer is thereby structured in such a manner that it is subdivided into individual two-dimensional portions which are assigned respectively to one solar cell. The metal layer in each of the portions has two regions which are electrically insulated from each other, the first region extending under the assigned solar cell and contacting the latter in an electrically conductive manner. The second region is likewise connected to the other electrical contact of the solar cell. In order to produce a parallel and series circuit of the individual solar cells, the individual portions of the metal layer are now connected to each other in a suitable manner by means of connecting portions which, for their part, are part of the metal layer. | 09-25-2008 |
| 20090126794 | Photovoltaic Concentrator Module With Multifunction Frame - The invention relates to a photovoltaic concentrator module with multifunction frame and also to a method for production thereof. The concentrator module has a lens—( | 05-21-2009 |
| 20090272427 | PHOTOVOLTAIC MODULE AND THE USE THEREOF - The present invention relates to a photovoltaic module, comprising at least two component cell groups (SCA) which are connected to each other and disposed on an electrically insulating basic body, which groups comprise respectively one solar cell which is applied on a thermally and electrically conductive carrier and a bypass diode which is applied at a spacing thereto, and which are contacted with each other via an electrical conductor, the bypass diode having a polarity which is inverse to the solar cell and the solar cell and the bypass diode being applied on the conductive carrier via a conductive connecting layer. | 11-05-2009 |
| 20110048501 | SOLAR CELL MODULE - The invention relates to a solar cell module comprising at least two assemblies (SCA) which are connected to each other and have solar cells and also a module base plate comprising an electrically conductive carrier structure and a rear-side plate which is electrically insulated at least on the side orientated towards the carrier structure. The assembly comprising the solar cell is thereby particularly small with respect to dimensioning, which leads to low material consumption of heat sink material, e.g. copper and aluminium, and hence enables particularly economical production. | 03-03-2011 |
| 20110127546 | REFLECTIVE SECONDARY LENS SYSTEM AND SEMICONDUCTOR ASSEMBLY AND ALSO METHOD FOR THE PRODUCTION THEREOF - The present invention relates to a reflective and/or refractive secondary lens system for focusing sunlight onto semiconductor elements, the secondary lens system being characterised according to the invention by a projection which is disposed around the basic body forming the secondary lens system. Furthermore, the present invention relates to a semiconductor assembly which includes the secondary lens system according to the invention, and also to a method for the production of this semiconductor assembly. In particular, this semiconductor assembly represents a concentrating solar cell module. | 06-02-2011 |
| 20110265852 | OPEN ENCAPSULATED CONCENTRATOR SYSTEM FOR SOLAR RADIATION - The invention relates to an open concentrator system for solar radiation comprising a hollow mirror and a photovoltaic module comprising a plurality of solar cells disposed in the focus of said hollow mirror, the photovoltaic module being encapsulated by a housing. The housing is thereby configured such that it has a transparent cover at least in the region of the incident radiation reflected by the hollow mirror and such that this transparent cover is at a spacing from photovoltaic module, i.e. is situated in the cone of the incident radiation. | 11-03-2011 |
| Patent application number | Description | Published |
|---|
| 20080254059 | Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby - Adenoviral serotypes differ in their natural tropism. The various serotypes of adenovirus have been found to differ in at least their capsid proteins (e.g., penton-base and hexon proteins), proteins responsible for cell binding (e.g., fiber proteins), and proteins involved in adenovirus replication. This difference in tropism and capsid proteins among serotypes has led to many research efforts aimed at redirecting the adenovirus tropism by modification of the capsid proteins. The present invention bypasses such requirement for capsid protein modification as it presents a recombinant, replication-defective adenovirus of serotype 26, a rare adenoviral serotype, and methods for generating the alternative, recombinant adenovirus. Additionally, means of employing the recombinant adenovirus for delivery and expression of heterologous genes are provided. | 10-16-2008 |
| 20090233992 | HEPATITIS C VIRUS VACCINE - The present invention features Ad6 vectors and a nucleic acid encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region. The nucleic acid is particularly useful as a component of an adenovector or DNA plasmid vaccine providing a broad range of antigens for generating an HCV specific cell mediated immune (CMI) response against HCV. | 09-17-2009 |
| 20100129901 | HEPATITIS C VIRUS VACCINE - The present invention features Ad6 vectors and a nucleic acid encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region. The nucleic acid is particularly useful as a component of an adenovector or DNA plasmid vaccine providing a broad range of antigens for generating an HCV specific cell mediated immune (CMI) response against HCV. | 05-27-2010 |
| 20100183651 | Broadly Representative Antigen Sequences and Method for Selection - A novel method for generating vaccine sequences is disclosed herein that preserves contiguous epitope length stretches of amino acids or nucleotides from an input pool of sequences. The method generates continuous, stepwise epitope consensus that together provides for a single globally optimized sequence. The end sequences are designed to maximize overlap between any potential epitope length sequence extract from a natural antigen sequence. The disclosed method, thus, allows one to maximize the number of potential natural epitopes that are mimicked in a resultant vaccine sequence. Various representative HIV vaccine sequences have been generated and are disclosed herein. | 07-22-2010 |
| 20100272714 | Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLs, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42. | 10-28-2010 |
| 20110159013 | Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLS, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42. | 06-30-2011 |
